KILITCH - Kilitch Drugs India

Kilitch Drugs India

KILITCH · Pharma > Pharmaceuticals & Drugs · MD: Mukund P Mehta · Listing date: Sept. 29, 2010 · Employees: 123 · Mumbai · http://www.kilitch.com

Stock Price vs Company Growth

1.1%

2.4%

7.5%

8.8%

8.3%

3.3%

18.8%

10y

27.9%

all

11.1%

🤔 How to analyze this graph?

Last Traded Price

₹ 312 1.1%

298

405

Company Overview

Sales

151 Cr

Growth: 9.1%

Profit after Tax

12.6 Cr

Growth: -13.8%

Small Cap

501 Cr

P/E: 39.6x

Industry P/E: 41.4x

Fundamentals

Sales (Cr)	₹ 151
Growth	9.1%
EBITDA	13.0%
P/S	3.3x
Dividend	0.0%
P/E	39.6x
Book Value	₹ 110
PEG Ratio	4.4x
ROE	7.4%
P/B	2.8x

Shareholding Pattern

Institutions

Dipak Kanayalal Shah

2.65 %

Iepf

1.5 %

Llp

0.05 %

Promoters

Kilitch Company (Pharma) Limited

42.6 %

Bhavin Mukund Mehta

12.87 %

Neeta Mukund Mehta

7.14 %

Mukund Mehta

5.72 %

Others

Increase Decrease No change

Company Profile Detailed

Kilitch Drugs is a pharmaceutical company, its services range from manufacturing to marketing a host of formulations in all dosage forms i.e. solid, liquid and parenteral forms. With nearly two decades of creating safe pharmaceutical solutions and the ultimate purpose of making the world a healthier place.Kilitch is one of the largest manufacturers of antibacterial parenteral formulations. It is also one of the largest producers of sterile liquid formulations in small volumes in India.

Investors (27)

iepf

dipak.ka...

dipak.sh...

Followers (1)

paras5